Hepatitis Foundation International   photo
The Good We Do Living with Hepatitis News and Research Support Education Donate Contact Us Home

 

Heplink Online Learning Center Subscribe to Our Newsletter E-Store

Clinical Trials Resource Center

About Research  |   Trials  |   NIH Trials  |   Email Notifications  |   FDA Approvals  |   Research Centers
Research Headlines  |   NMT Results  |   Bookstore


Therapeutic Areas: Cardiology/Vascular Diseases

Atrial Flutter Clinical Trials


A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alaska

Anchorage : ARCA Clinical Research Site #157

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

California

Pasadena : ARCA Clinical Research Site #320

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Sacramento : ARCA Clinical Research Site # 132

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Colorado

Aurora : ARCA Clinical Research Site #153

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Florida

Tampa : ARCA Clinical Research Site #184

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Georgia

Atlanta : Emory University Hospital Midtown

A clinical trial seeking patients for a research study for the treatment of Cardiac Catheter Ablation, Atrial Flutter or Cardiac Arrhythmias

Atlanta : Emory University Hospital

A clinical trial to evaluate treatments using Catheter ablation for patients with Atrial Flutter or Arrhythmia

Illinois

Gurnee : ARCA Clinical Research Site #194

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Indiana

Hammond : ARCA Clinical Research Site #303

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Michigan

Lansing : ARCA Clinical Research Site #162

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Royal Oak : ARCA Clinical Research Site #105

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nebraska

Lincoln : ARCA Clinical Research Site #152

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Omaha : ARCA Clinical Research Site #176

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New Jersey

Elmer : ARCA Clinical Research Site #161

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New York

Albany : ARCA Clinical Research Site # 179

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ohio

Columbus : ARCA Clinical Research Site #151

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oklahoma

Oklahoma City : ARCA Clinical Research Site #123

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pennsylvania

Hershey : ARCA Clinical Research Site # 189

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Lancaster : ARCA Clinical Research Site #109

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Wyomissing : ARCA Clinical Research Site #114

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tennessee

Jackson : ARCA Clinical Research Site #198

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nashville : Vanderbilt University Medical Center

A clinical research study of dabigatran etexilate mesylate for the treatment of Atrial Fibrillation or Atrial Flutter

Texas

Austin : ARCA Clinical Research Site #316

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Beaumont : ARCA Clinical Research Site #160

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Virginia

Norfolk : ARCA Research Site #131

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Washington

Puyallup : ARCA Clinical Research Site #196

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Bulgaria

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Sofia :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Varna :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Canada

London : London Health Sciences Center

A clinical trial to evaluate treatments using tricuspid isthmus imaging with Cartosound for patients with Atrial Flutter

France

Creteil :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Grenoble : CHU Grenoble

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Rennes : CHU de Rennes

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Rouen : University Hospital of Rouen

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Toulouse : Clinique Pasteur

Patients are needed to participate in a clinical research study evaluating Atrial flutter ablation and Atrial flutter ablation and pulmonary vein isolation for the treatment of Atrial Flutter or Atrial Fibrillation

Germany

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Rostock : Universitiy Medical Centre Rostock

A clinical research study of Antiarrhythmic drug, Cavo-tricuspid-isthmus-ablation and Pulmonary vein isolation for the treatment of Atrial Fibrillation or Atrial Flutter

Poland

Krakow :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lodz :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Lublin :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Wroclaw :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Russian Federation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Turkey

Istanbul :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Istanbul :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Istanbul :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Samsun :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Ukraine

Donetsk :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Kiev :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

Many Locations :

Patients are needed to participate in a clinical research study of no drug to evaluate Atrial Fibrillation

Uzhhorod :

Patients are needed to participate in a clinical research study evaluating Rivaroxaban (Xarelto, BAY59-7939) for the treatment of Atrial Fibrillation

the good we do  |  living with hepatitis  |  news & research  |  support donate  |  contact us  |  site map  |   home

nnac  |  online learning center  |  subscribe to our newsletter   |   disclaimer  |  privacy

 

 

Hepatitis Foundation International
(800) 891-0707
HFI@comcast.net

©2003. All rights reserved.